The partnership grants Fosun Diagnostics rights to distribute immune profiling tools—including ELISpot assay plates—in Thailand, Vietnam, Indonesia, the Philippines, Singapore, and Malaysia. While the agreement establishes a broad framework for expansion, the initial rollout centers on tuberculosis research in Thailand, where Fosun has already identified specific customer demand. Pricing under the contract utilizes a tiered volume structure designed to accommodate scalable commercial economics as the products penetrate new regions.
Virax Biolabs Secures Southeast Asia Distribution Deal with Fosun
Virax Biolabs has signed an exclusive multi-country supply agreement with Fosun Diagnostics to deploy its ImmuneSelect immune profiling product line across six Southeast Asian markets. The deal bypasses the company’s clinical-stage diagnostic pipeline to focus on immediate, purchase-order-driven revenue through regional research and diagnostic networks.
James Foster, CEO of Virax Biolabs, described the move as a critical step in establishing a structured commercial footprint in Asia. For Fosun Diagnostics, a subsidiary of the global healthcare group Fosun Pharma, the partnership provides a specialized set of tools to bolster its existing regional diagnostic infrastructure. The agreement remains distinct from the development of ViraxImmune, the company’s separate T cell-based diagnostic platform currently undergoing regulatory evaluation. Both parties intend to use this framework to explore future opportunities, including private-label arrangements and broader product offerings for the ASEAN market.
Comments (0)
No comments yet. Be the first!